A randomized trial of a primary care-based disease management program to improve cardiovascular risk factors and glycated hemoglobin levels in patients with diabetes

Our comprehensive disease management program reduced cardiovascular risk factors and A1C levels among vulnerable patients with type 2 diabetes and poor glycemic control.